Clinical Trial Update: Neural Responses and Dysphoria: Modulation by a Pharmacological Probe [Phase 4]

View source ↗

Summary

The University of Oxford reports the completion of a Phase 4 clinical trial investigating neural responses and dysphoria, with modulation by a pharmacological p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysphoria

Snippet

Sponsor: University of Oxford | Conditions: Dysphoria | Phase 4 | Status: COMPLETED